These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1624848)
21. In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium. Mitsuyama J; Itoh Y; Takahata M; Okamoto S; Yasuda T Antimicrob Agents Chemother; 1992 Sep; 36(9):2030-6. PubMed ID: 1329639 [TBL] [Abstract][Full Text] [Related]
22. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin]. Yamashiro Y; Nunome M; Takahata M; Yasuda T Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases. Suzuki K; Fujisawa T; Nakashima M; Hamasaki R J Infect Chemother; 2005 Oct; 11(5):253-5. PubMed ID: 16258823 [TBL] [Abstract][Full Text] [Related]
25. [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. Maekawa M; Fukuda Y; Sugiura Y; Kamiyama T; Futakuchi N; Takahata M; Mitsuyama J Jpn J Antibiot; 2003 Feb; 56(1):27-35. PubMed ID: 12723396 [TBL] [Abstract][Full Text] [Related]
26. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of single-dose therapy with levofloxacin for acute cystitis: comparison to three-day therapy]. Koyama Y; Mikami O; Matsuda T; Murota T; Ohara T; Kawamura H; Amazutsumi K; Uchida J; Harada T Hinyokika Kiyo; 2000 Jan; 46(1):49-52. PubMed ID: 10723666 [TBL] [Abstract][Full Text] [Related]
28. [Comparative studies of enoxacin and amoxicillin for acute uncomplicated cystitis in women]. Bischoff W Infection; 1986; 14 Suppl 3():S209-10. PubMed ID: 3463544 [TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group. Jardin A; Cesana M Antimicrob Agents Chemother; 1995 Jan; 39(1):215-20. PubMed ID: 7695309 [TBL] [Abstract][Full Text] [Related]
31. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study]. Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV Urologiia; 2009; (3):18-21. PubMed ID: 19670810 [TBL] [Abstract][Full Text] [Related]
32. Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Goto T; Kitagawa T; Kawahara M; Hayami H; Ohi Y Hinyokika Kiyo; 1999 Feb; 45(2):85-9. PubMed ID: 10212779 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards]. Aihara M; Oguri T; Kanno H; Kubo S; Honda M; Satoh K; Daimon Y; Yamanaka K; Sugawara K; Furuta T Rinsho Byori; 1992 Jan; 40(1):73-80. PubMed ID: 1312183 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial. Sadahira T; Wada K; Araki M; Ishii A; Takamoto A; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y; Kumon H; J Antimicrob Chemother; 2017 Feb; 72(2):529-534. PubMed ID: 27733519 [TBL] [Abstract][Full Text] [Related]
35. In-vitro activity of tosufloxacin, a new quinolone antibacterial agent. Cooper MA; Andrews JM; Wise R J Antimicrob Chemother; 1992 Jun; 29(6):639-47. PubMed ID: 1506348 [TBL] [Abstract][Full Text] [Related]
36. [Recurrence of acute uncomplicated cystitis--criteria for the evaluation of recurrence after antimicrobial chemotherapy]. Arakawa S; Kamidono S; Ishigami J; Kawamura N; Ohkoshi M; Ban Y; Nishiura T; Kumamoto Y; Kishi H; Kawada Y Hinyokika Kiyo; 1986 May; 32(5):697-711. PubMed ID: 3751797 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin]. Guibert J; Herman H; Capron MH Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058 [TBL] [Abstract][Full Text] [Related]
38. [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae]. Sakata H Jpn J Antibiot; 2012 Jun; 65(3):173-9. PubMed ID: 23173293 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological properties of A-71497: a prodrug of tosufloxacin. Chu DT; Lico IM; Swanson RN; Marsh KC; Plattner JJ; Pernet AG Drugs Exp Clin Res; 1990; 16(9):435-43. PubMed ID: 2100244 [TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin. Yamada M; Hatou S; Yoshida J Eye Contact Lens; 2008 Mar; 34(2):109-12. PubMed ID: 18327047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]